Cargando…

The use of adjuvant chemotherapy is not associated with recurrence or cancer-specific death following curative resection for stage III rectal cancer: a competing risks analysis

BACKGROUND: The role of adjuvant chemotherapy (AC) in stage III rectal cancer (RC) has been argued based on evidence from its use in colon cancer. Previous trials have analysed disease-free and overall survivals as endpoints, rather than disease recurrence. This study compares the competing risks in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ng, Kheng-Seong, Chan, Charles, Rickard, Matthew John Francis Xavier, Keshava, Anil, Stewart, Peter, Chapuis, Pierre Henri
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10193597/ https://www.ncbi.nlm.nih.gov/pubmed/37198644 http://dx.doi.org/10.1186/s12957-023-03021-w

Ejemplares similares

Cost-effectiveness of adjuvant chemotherapy with uracil–tegafur for curatively resected stage III rectal cancer
por: Hisashige, A, et al.
Publicado: (2008)

Adjuvant chemotherapy in curatively resected rectal cancer: How valid are the data?
por: Manzini, Giulia, et al.
Publicado: (2020)

Effects of Adjuvant Therapy Compliance and Anastomotic Leakage on the Oncologic Outcomes of Patients With Rectal Cancer After Curative Resection
por: Fang, Chao, et al.
Publicado: (2020)

An individual patient data meta-analysis of adjuvant therapy with uracil–tegafur (UFT) in patients with curatively resected rectal cancer
por: Sakamoto, J, et al.
Publicado: (2007)

The effect of comorbidity on the use of adjuvant chemotherapy and type of regimen for curatively resected stage III colon cancer patients
por: Hsieh, Mei‐Chin, et al.
Publicado: (2016)

Anatomic Basis of Sharp Pelvic Dissection for Curative Resection of Rectal Cancer
por: Kim, Nam Kyu
Publicado: (2005)

Local recurrence after curative resection for rectal carcinoma: The role of surgical resection
por: Yun, Jung-A, et al.
Publicado: (2016)

Cost-effectiveness of adjuvant chemotherapy for curatively resected gastric cancer with S-1
por: Hisashige, Akinori, et al.
Publicado: (2013)

S-1 Based Doublet as an Adjuvant Chemotherapy for Curatively Resected Stage III Gastric Cancer: Results from the Randomized Phase III POST Trial
por: Lee, Choong-kun, et al.
Publicado: (2019)

Adjuvant radiotherapy for the treatment of stage IV rectal cancer after curative resection: A propensity score-matched analysis and meta-analysis
por: Kim, Min Jung, et al.
Publicado: (2016)

A Double Metachronous Ureter Metastasis following Curative Resection of Rectal Cancer
por: Aghalarov, Ilgar, et al.
Publicado: (2021)

Circumferential Resection Margin Involvement in Stage III Rectal Cancer Patients Treated with Curative Resection Followed by Chemoradiotherapy: A Surrogate Marker for Local Recurrence?
por: Kang, Jeonghyun, et al.
Publicado: (2013)

Impact of Adjuvant Chemotherapy in Patients With Curatively Resected Stage IV Colorectal Cancer
por: Kobayashi, Hirotoshi, et al.
Publicado: (2015)

Prognostic impact of preoperatively elevated and postoperatively normalized carcinoembryonic antigen levels following curative resection of stage I‐III rectal cancer
por: Nakamura, Yuya, et al.
Publicado: (2019)

The risk factors for benign small bowel obstruction following curative resection in patients with rectal cancer
por: Tang, Liang, et al.
Publicado: (2018)

Factors predicting recurrence after curative resection for rectal cancer: a 16-year study
por: Farhat, Waad, et al.
Publicado: (2019)

Role of Serum Carcinoembryonic Antigen in Predicting Recurrent Disease following Curative Resection of Rectal Cancer
por: Soma, Srikanth, et al.
Publicado: (2022)

Right- and left-sided stage III colon cancers present different prognostic outcomes of oxaliplatin-based adjuvant chemotherapy after curative resection
por: Peng, Jianhong, et al.
Publicado: (2018)

Apurinic/apyrimidinic endonuclease 1 is associated with poor prognosis after curative resection followed by adjuvant chemotherapy in patients with stage III colon cancer
por: Song, Ji Hyeong, et al.
Publicado: (2022)

Simultaneous total laparoscopic curative resection for synchronous gastric, cecal and rectal cancer: Report of a case
por: Iwatsuki, Masaaki, et al.
Publicado: (2014)

Is adjuvant radiotherapy warranted in resected pT1-2 node-positive rectal cancer?
por: Peng, Junjie, et al.
Publicado: (2013)

Association between adjuvant chemotherapy and survival in stage I gastric cancer patients after curative resection
por: Chen, Qiuying, et al.
Publicado: (2023)

Rectal cancer treatment and outcomes in elderly patients treated with curative intent
por: Kang, Sharlyn, et al.
Publicado: (2021)

Adjuvant therapy in patients with rectal adenocarcinoma treated with neoadjuvant chemoradiotherapy and radical resection in pathological stages I–III
por: Lino-Silva, Leonardo S., et al.
Publicado: (2020)

A competing risk analysis of colorectal cancer recurrence after curative surgery
por: Schellenberg, Angela E., et al.
Publicado: (2022)

Which Definition of Upper Rectal Cancer Is Optimal in Selecting Stage II or III Rectal Cancer Patients to Avoid Postoperative Adjuvant Radiation?
por: Gao, Xian Hua, et al.
Publicado: (2021)

Isolated liver metastasis detected 11 years after the curative resection of rectal cancer: A case report
por: Yonenaga, Yoshikuni, et al.
Publicado: (2021)

Is adjuvant chemotherapy necessary for patients with ypT0–2N0 rectal cancer treated with neoadjuvant chemoradiotherapy and curative surgery?
por: Lu, Zhao, et al.
Publicado: (2018)

Adjuvant transarterial chemoembolization to improve the prognosis of hepatocellular carcinoma following curative resection
por: Kuang, Xuejun, et al.
Publicado: (2018)

Prognostic Role of BRAF Mutation in Stage II/III Colorectal Cancer Receiving Curative Resection and Adjuvant Chemotherapy: A Meta-Analysis Based on Randomized Clinical Trials
por: Zhu, Lizhen, et al.
Publicado: (2016)

High pretreatment serum CA19-9 level predicts a poor prognosis for patients with stage III colon cancer after curative resection and adjuvant chemotherapy
por: Zhou, Wenhao, et al.
Publicado: (2019)

Preoperative neutrophil/lymphocyte ratio predicts overall survival but does not predict recurrence or cancer-specific survival after curative resection of node-positive colorectal cancer
por: Jankova, Lucy, et al.
Publicado: (2013)

A Case of Long-term Survival after Curative Resection for Synchronous Solitary Adrenal Metastasis from Rectal Cancer
por: Chen, Linlin, et al.
Publicado: (2014)

The impact of anastomotic leakage on oncology after curative anterior resection for rectal cancer: A systematic review and meta-analysis
por: Ma, Lushun, et al.
Publicado: (2020)

Prognostic value of ABO blood group in a Chinese population in Northwest China region with curatively resected rectal cancer
por: Wei, Jiangpeng, et al.
Publicado: (2019)

Preoperative controlling nutritional status (CONUT) score as a predictor of long-term outcome after curative resection followed by adjuvant chemotherapy in stage II-III gastric Cancer
por: Liu, Xuechao, et al.
Publicado: (2018)

Randomized trial of adjuvant chemotherapy versus control after curative resection for gastric cancer: 5-year follow-up
por: Neri, B, et al.
Publicado: (2001)

Is there a survival benefit from adjuvant chemotherapy for patients with liver oligometastases from colorectal cancer after curative resection?
por: Pan, Zhizhong, et al.
Publicado: (2018)

Clinical implications of dihydropyrimidine dehydrogenase expression in patients with pancreatic cancer who undergo curative resection with S-1 adjuvant chemotherapy
por: Murakawa, Masaaki, et al.
Publicado: (2017)

Adjuvant Immunotherapy in Curative Intent Esophageal Cancer Resection Patients: Real-World Experience within an Integrated Health System
por: Kwak, Hyunjee V., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_og9anj81n3q184fmhlbn411peb